Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity

Masayoshi Harigai, Tsutomu Takeuchi, Yoshiya Tanaka, Tsukasa Matsubara, Hisashi Yamanaka, Nobuyuki Miyasaka

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Fingerprint Dive into the research topics of 'Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity'. Together they form a unique fingerprint.

Medicine & Life Sciences